Atlas Trials

Neo-adjuvant Trial With AZD9291 in EGFRm+ Stage IIIA/B NSCLC

Clinical trial NCT02824952 · UNKNOWN

Trial details

NCT number
NCT02824952
Sponsor
Shaare Zedek Medical Center
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Cancer, Non-small Cell
Start date
2018-11-01
Primary completion
2022-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.